271
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Factors for Cardiovascular Events in Elderly Patients with Community Acquired Pneumonia: Results from the CAP-China Network

ORCID Icon, ORCID Icon, , , , , ORCID Icon, ORCID Icon, , & show all
Pages 603-614 | Published online: 23 Apr 2022

References

  • Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020;37(4):1302–1318. doi:10.1007/s12325-020-01248-7
  • Cillóniz C, Dominedò C, Pericàs JM, Rodriguez-Hurtado D, Torres A. Community-acquired pneumonia in critically ill very old patients: a growing problem. Eur Respir Rev. 2020;29(155):190126. doi:10.1183/16000617.0126-2019
  • Han X, Liu X, Chen L, et al. Disease burden and prognostic factors for clinical failure in elderly community acquired pneumonia patients. BMC Infect Dis. 2020;20(1):668. doi:10.1186/s12879-020-05362-3
  • Han X, Zhou F, Li H, et al. Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia. BMC Infect Dis. 2018;18(1):192. doi:10.1186/s12879-018-3098-5
  • Furman CD, Leinenbach A, Usher R, Elikkottil J, Arnold FW. Pneumonia in older adults. Curr Opin Infect Dis. 2021;34(2):135–141. doi:10.1097/QCO.0000000000000718
  • World Health Organization. The top 10 causes of death. Avialable from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed April 20, 2022.
  • Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–1217. doi:10.1016/j.cell.2013.05.039
  • Corrales-Medina VF, Alvarez KN, Weissfeld LA, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313:264–274. doi:10.1001/jama.2014.18229
  • Corrales-Medina VF, Taljaard M, Fine MJ, et al. Risk stratification for cardiac complications in patients hospitalized for community-acquired pneumonia. Mayo Clin Proc. 2014;89(1):60–68. doi:10.1016/j.mayocp.2013.09.015
  • Tralhão A, Póvoa P. Cardiovascular events after community‐acquired pneumonia: a global perspective with systematic review and meta‐analysis of observational studies. J Clin Med. 2020;9(2):414. doi:10.3390/jcm9020414
  • Chen L, Han X, Li Y, Zhang C, Xing X. Complications of cardiovascular events in patients hospitalized with influenza-related pneumonia. Infect Drug Resist. 2021;14:1363–1373. doi:10.2147/IDR.S305509
  • Pieralli F, Vannucchi V, Nozzoli C, et al. Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study. BMC Infect Dis. 2021;21(1):116. doi:10.1186/s12879-021-05781-w
  • Putot A, Bouhey E, Tetu J, et al. Troponin elevation in older patients with acute pneumonia: frequency and prognostic value. J Clin Med. 2020;9(11):3623. doi:10.3390/jcm9113623
  • Ross R, Epstein FH. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–126. doi:10.1056/NEJM199901143400207
  • Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis. 2010;10:83–92. doi:10.1016/S1473-3099(09)70331-7
  • Aliberti S, Ramirez JA. Cardiac diseases complicating community-acquired pneumonia. Curr Opin Infect Dis. 2014;27(3):295–301. doi:10.1097/QCO.0000000000000055
  • Violi F, Carnevale R, Calvieri C, et al. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia. Thorax. 2015;70:961–966. doi:10.1136/thoraxjnl-2015-207178
  • Rae N, Finch S, Chalmers JD. Cardiovascular disease as complication of community-acquired pneumonia. Curr Opin Pulm Med. 2016;22(3):212–218. doi:10.1097/MCP.0000000000000261
  • Musher DM, Abers MS, Corrales-Medina VF, Longo DL. Acute Infection and Myocardial Infarction. N Engl J Med. 2019;380(2):171–176. doi:10.1056/NEJMra1808137
  • Sibelius U, Grandel U, Buerke M, et al. Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. Circulation. 2000;101(1):78–85. doi:10.1161/01.CIR.101.1.78
  • Putot A, Chague F, Manckoundia P, Cottin Y, Zeller M. Post-infectious myocardial infarction: new insights for improved screening. J Clin Med. 2019;8(6):827. doi:10.3390/jcm8060827
  • Violi F, Cangemi R, Falcone M, et al. Cardiovascular complications and short-term mortality risk in community-acquired pneumonia. Clin Infect Dis. 2017;64(11):1486–1493. doi:10.1093/cid/cix164
  • Aliberti S, Ramirez J, Cosentini R, et al. Acute myocardial infarction versus other cardiovascular events in community-acquired pneumonia. ERJ Open Res. 2015;1(1):00020–2015. doi:10.1183/23120541.00020-2015
  • Cangemi R, Calvieri C, Falcone M, et al. Relation of cardiac complications in the early phase of community-acquired pneumonia to long-term mortality and cardiovascular events. Am J Cardiol. 2015;116(4):647–651. doi:10.1016/j.amjcard.2015.05.028
  • Corrales-Medina VF, Musher DM, Wells GA, Chirinos JA, Chen L, Fine MJ. Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality. Circulation. 2012;125(6):773–781. doi:10.1161/CIRCULATIONAHA.111.040766
  • Viasus D, Garcia-Vidal C, Manresa F, Dorca J, Gudiol F, Carratalà J. Risk stratification and prognosis of acute cardiac events in hospitalized adults with community acquired pneumonia. J Infect. 2013;66(1):27–33. doi:10.1016/j.jinf.2012.09.003
  • Medical Letter on Drugs and Therapeutics. Corticosteroids in Community-Acquired Pneumonia. JAMA. 2020;323(9):887–888. doi:10.1001/jama.2020.0216
  • Jiang S, Liu T, Hu Y, et al. Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis. Medicine. 2019;98(26):e16239. doi:10.1097/MD.0000000000016239
  • Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677–686. doi:10.1001/jama.2015.88
  • Cangemi R, Falcone M, Taliani G, et al. Corticosteroid use and incident myocardial infarction in adults hospitalized for community‐acquired pneumonia. Ann Am Thorac Soc. 2019;16(1):91–98. doi:10.1513/AnnalsATS.201806-419OC
  • Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis. 2008;47(2):182–187. doi:10.1086/589246
  • Petroianni A, Ceccarelli D, Conti V, Terzano C. Aspiration pneumonia. Pathophysiological aspects, prevention and management. A review. Panminerva Med. 2006;48(4):231–239.
  • Singanayagam A, Singanayagam A, Elder DH, Chalmers JD. Is community-acquired pneumonia an independent risk factor for cardiovascular disease? Eur Respir J. 2012;39(1):187–196. doi:10.1183/09031936.00049111
  • Feng DY, Zou XL, Zhou YQ, Wu WB, Yang HL, Zhang TT. Combined neutrophil-to-lymphocyte ratio and CURB-65 score as an accurate predictor of mortality for community-acquired pneumonia in the elderly. Int J Gen Med. 2021;14:1133–1139. doi:10.2147/IJGM.S300776
  • Kang Y, Fang XY, Wang D, Wang XJ. Activity of daily living upon admission is an independent predictor of in-hospital mortality in older patients with community acquired pneumonia. BMC Infect Dis. 2021;21(1):314. doi:10.1186/s12879-021-06006-w
  • Yoshikawa H, Komiya K, Yamamoto T, et al. Quantitative assessment of erector spinae muscles and prognosis in elderly patients with pneumonia. Sci Rep. 2021;11(1):4319. doi:10.1038/s41598-021-83995-3
  • Leroy O, Bosquet C, Vandenbussche C, et al. Community-acquired pneumonia in the intensive care unit: epidemiological and prognosis data in older people. J Am Geriatr Soc. 1999;47(5):539–546. doi:10.1111/j.1532-5415.1999.tb02567.x